NCT01420445View on ClinicalTrials.gov

Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Acute BronchitisChronic Bronchitis
Interventions
DRUG

YHD001 dose level 1

three times daily / 7 days

DRUG

YHD001 dose level 2

three times daily / 7 days

DRUG

Pelargonium sidoides extract

6-9mL three times daily / 7 days

DRUG

placebo

three times daily / 7 days

Trial Locations (1)

137-701

The Catholic University of Korea Seoul St. Mary'S Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01420445 - Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis | Biotech Hunter | Biotech Hunter